Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 113,739 | 107,382 | 104,061 | 107,199 | 108,637 |
| Gross Profit | 113,739 | 107,382 | 104,061 | 107,199 | 108,637 |
| Operating Expenses | 73,716 | 1,190,521 | 43,964 | 38,836 | 40,164 |
| Operating Income | 40,023 | -1,083,139 | 60,097 | 68,363 | 68,473 |
| Interest Expense | 9,839 | 1,840 | 1,527 | 1,526 | 1,524 |
| Other Income | 1,748 | 8,757 | 7,291 | 5,428 | 2,958 |
| Pre-tax Income | 31,932 | -1,076,222 | 65,861 | 72,265 | 69,907 |
| Income Tax | 17,982 | 13,256 | 20,147 | 23,398 | 19,590 |
| Net Income Continuous | 13,950 | -1,089,478 | 45,714 | 48,867 | 50,317 |
| Minority Interests | -1,371 | -27,291 | N/A | N/A | N/A |
| Net Income | $15,321 | $-1,062,187 | $45,714 | $48,867 | $50,317 |
| EPS Basic Total Ops | 0.10 | -6.84 | 0.30 | 0.31 | 0.33 |
| EPS Basic Continuous Ops | 0.09 | -7.01 | 0.30 | 0.32 | 0.33 |
| EPS Diluted Total Ops | 0.09 | -6.84 | 0.25 | 0.26 | 0.28 |
| EPS Diluted Continuous Ops | 0.07 | -7.01 | 0.24 | 0.26 | 0.27 |
| EBITDA(a) | $40,530 | $-1,082,869 | $60,383 | $68,703 | $68,836 |